The Steve Gleason Institute for Neuroscience opens the doors to a thriving world for individuals and families impacted by neurodegenerative diseases. We bring scientists, clinicians, and educators together with the goal of improving the quality of life for those affected by these diseases. Our institution helps all to prosper despite the many challenges they face. With a culture of perseverance and fellowship, the Gleason Institute’s spirit advances adaptive technology, research, and independence for those with neurodegenerative diseases.
We are proud to have a diverse group of talented individuals united toward common goals.
Our approach combines three focuses:
This collaboration fosters the development of new technologies and treatments, and provides education and support to individuals, caregivers, and families.
Visit the ATC to explore tangible solutions for improving independence and quality of life with a variety of technologies.
Learn about seed grant opportunities to identify avenues for new treatments, biomarkers, and predictive diagnostics for neurodegenerative diseases.
Read more about our clinical partnerships that provide connections to patient services (e.g. neurology, PT, OT) and run selected clinical trials.